Issue Date: July 23, 2012
MedImmune To Close Two California Sites
MedImmune, the biologics arm of drugmaker AstraZeneca, will close research facilities in Mountain View and Santa Clara, Calif., eliminating approximately 200 jobs. It will relocate another 100 jobs to other MedImmune facilities, including one in Hayward, Calif. The closure is part of a two-year consolidation and cost-cutting program announced by AstraZeneca in February. It is expected to be completed in 2014.
- Chemical & Engineering News
- ISSN 0009-2347
- Copyright © American Chemical Society